AbbVie Inc.: Drug Recall
Recall #D-0088-2024 · 10/17/2023
Class III: Low Risk
Recall Details
- Recall Number
- D-0088-2024
- Classification
- Class III
- Product Type
- Drug
- Recalling Firm
- AbbVie Inc.
- Status
- Ongoing
- Date Initiated
- 10/17/2023
- Location
- North Chicago, IL, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 864 cartons
Reason for Recall
Labeling: Wrong Barcode- One (1) of every forty (40) unit dose blister will contain incorrect barcode information that causes a 125mcg unit dose is scanned as 200mcg unit dose.
Product Description
Synthroid, Levothyroxine Sodium Tablets, USP 125mcg (0.125mg), 100-count bottle, Rx Only AbbVie Inc. North Chicago, IL 60064, U.S.A. NDC 0074-7068-11
Distribution Pattern
Distributed in the US. No government or foreign consignees.
Other Recalls by AbbVie Inc.
- Class II: Risk 09/16/2024
- Class II: Risk 09/16/2024
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.